Search for Clinical Trial Results

Sponsored By

Intraocular Melanoma - 24 Studies Found

Status Study
Not yet recruiting Study Name: Vorinostat in Patients With Class 2 High Risk Uveal Melanoma
Condition: Uveal Melanoma
Date: 2016-12-21
Interventions: Drug: Vorinostat Study participants who meet the criteria of Class 2 uveal melanoma and no radiologic ev
Recruiting Study Name: Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Condition: Uveal Melanoma
Date: 2011-09-15
Recruiting Study Name: Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma
Condition: Uveal Melanoma
Date: 2013-09-17
Interventions: Biological: Autologous Dendritic Cells loaded with autologous Tumor RNA
Completed Study Name: Study of Tumor Samples in Patients Undergoing Radiation Therapy or Surgery For Primary Melanoma of the Eye
Condition: Intraocular Melanoma
Date: 2009-08-05
Interventions:
  • Genetic: fluorescence in situ hybridization

Completed Study Name: Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
Condition: Intraocular Melanoma
Date: 2010-10-07
Interventions:
  • Biological: bevacizumab
  • Drug: temozolomide
Completed Study Name: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery
Condition: Intraocular Melanoma
Date: 2008-08-19
Interventions: Drug: nab-paclitaxel 150 mg/m2 weekly for 3 of 4 weeks every 28 days.
Active, not recruiting Study Name: Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients
Condition: Uveal Melanoma
Date: 2011-09-06
Interventions: Drug: AEB071
Recruiting Study Name: Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Date: 2016-05-10
Interventions: Drug: Selumetinib 100mg, 125mg, 150mg, 175mg, 200mg or 225
Active, not recruiting Study Name: Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Condition: Uveal Melanoma
Date: 2016-07-21
Interventions:
  • Drug: Adjuvant chemotherapy by Fotemustin

Recruiting Study Name: Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis
Condition: Uveal Melanoma
Date: 2016-09-09
Interventions:
  • Procedure: SIRT catheter-based
Next >>>